The macrophage activation marker sCD163 combined with markers of the Enhanced Liver Fibrosis (ELF) score predicts clinically significant portal hypertension in patients with cirrhosis
暂无分享,去创建一个
H. Møller | T. Sandahl | H. Grønbæk | H. Vilstrup | F. Bendtsen | J. García‐Pagán | E. Reverter | V. Hernández-Gea | S. Møller | F. Bendtsen | F. Turon | R. McGrail